Agency Information Collection Activities; Proposed eCollection, eComments Requested; Extension Without Change of a Previously Approved Collection; Application for Import Quota for Ephedrine, Pseudoephedrine, and Phenylpropanolamine; DEA Form 488, 6439-6440 [2019-03354]

Download as PDF Federal Register / Vol. 84, No. 39 / Wednesday, February 27, 2019 / Notices campground and day use business plans was announced on April 12, 2018 through a BLM public news release, letters mailed to local governments and major stakeholders, by providing information on the BLM website, and posting written notices at each fee site. The draft business plans were publicly available for review and comment on the BLM Utah business plan website from April 11, 2018 until May 12, 2018. Following FLREA guidelines, the Utah Recreation RAC reviewed and recommended the new fee proposals at their meeting on May 22, 2018. Fee amounts will be posted on-site, and copies of the business plan will be available at the Field Offices and the BLM Utah State Office, and posted online. Authority: 16 U.S.C. 6803 and 43 CFR 2933. Edwin L. Roberson, State Director. [FR Doc. 2019–03385 Filed 2–26–19; 8:45 am] BILLING CODE 4310–DQ–P INTERNATIONAL TRADE COMMISSION [Investigation No. 337–TA–1114] Certain Modular LED Display Panels and Components Thereof; Notice of Commission Determination Not To Review an Initial Determination Terminating the Investigation in Its Entirety; Termination of Investigation U.S. International Trade Commission. ACTION: Notice. AGENCY: Notice is hereby given that the U.S. International Trade Commission (‘‘Commission’’) has determined not to review an initial determination (‘‘ID’’) (Order No. 29) terminating the investigation in its entirety based on withdrawal of the operative complaint by Complainant Ultravision Technologies, LLC of Dallas, Texas (‘‘Ultravision’’). FOR FURTHER INFORMATION CONTACT: Carl P. Bretscher, Office of the General Counsel, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436, telephone 202– 205–2382. Copies of non-confidential documents filed in connection with this investigation are or will be available for inspection during official business hours (8:45 a.m. to 5:15 p.m.) in the Office of the Secretary, U.S. International Trade Commission, 500 E Street SW, Washington, DC 20436, telephone 202–205–2000. General amozie on DSK3GDR082PROD with NOTICES1 SUMMARY: VerDate Sep<11>2014 17:07 Feb 26, 2019 Jkt 247001 information concerning the Commission may also be obtained by accessing its internet server (https://www.usitc.gov). The public record for this investigation may be viewed on the Commission’s Electronic Docket Information System (‘‘EDIS’’) (https://edis.usitc.gov). Hearing-impaired persons are advised that information on this matter can be obtained by contacting the Commission’s TDD terminal, telephone 202–205–1810. SUPPLEMENTARY INFORMATION: On May 31, 2018, the Commission instituted this investigation based on a complaint (and amendment and supplement thereto) filed by Ultravision. 83 FR 25044 (May 31, 2018). The amended and supplemented complaint alleged a violation of 19 U.S.C. 1337, as amended (‘‘Section 337’’), in the importation into the United States, sale for importation, or sale within the United States after importation of certain modular LED display panels and components thereof that infringe the asserted claims of U.S. Patent Nos. 9,349,306 (‘‘the ’306 patent’’) and 9,916,782 (‘‘the ’782 patent’’). The Commission’s notice of investigation named forty (40) parties as respondents, including but not limited to Shanghai Sansi Electronic Engineering Co., Ltd. and Sansi North America, LLC (collectively ‘‘Sansi’’), the subjects of the present ID. Id.; Order No. 29 at 2. The Office of Unfair Import Investigations (‘‘OUII’’) was also named as a party to the investigation. The Commission determined not to review previous IDs that partially terminated the investigation with respect to certain patent claims or certain parties. See, e.g., Comm’n Notice (Nov. 19, 2018); Comm’n Notice (Oct. 2, 2018); Comm’n Notice (Sept. 28, 2018); Comm’n Notice (July 24, 2018). The Commission also determined not to review previous IDs that found certain respondents in default. See, e.g., Comm’n Notice (Sept. 26, 2018); Comm’n Notice (Sept. 18, 2018); Comm’n Notice (Sept. 17, 2018). On November 27, 2018, Ultravision moved to terminate the investigation in its entirety based on its withdrawal of the amended complaint, the operative complaint in this investigation. Order No. 29 at 1. Consistent with Commission Rule 210.21(a)(1), Ultravision stated in its motion that it had entered into a confidential term sheet agreement with Sansi. Id. at 2. On November 30, 2018, OUII filed a response supporting the motion. See id. at 1. No other party filed a response to the motion. On January 31, 2019, the ALJ issued the subject ID granting the motion and PO 00000 Frm 00086 Fmt 4703 Sfmt 4703 6439 finding no ‘‘extraordinary circumstances that warrant denying the motion’’ under Commission Rule 210.21(a)(1), 19 CFR 210.21(a). No party filed a petition seeking review of the subject ID. Upon review of the entire record, including the ALJ’s ID, the Commission has determined not to review the subject ID. The investigation is hereby terminated in its entirety. The authority for the Commission’s determination is contained in Section 337 of the Tariff Act of 1930, as amended (19 U.S.C. 1337), and in part 210 of the Commission’s Rules of Practice and Procedure (19 CFR part 210). By order of the Commission. Issued: February 21, 2019. Lisa Barton, Secretary to the Commission. [FR Doc. 2019–03340 Filed 2–26–19; 8:45 am] BILLING CODE 7020–02–P DEPARTMENT OF JUSTICE [OMB Number 1117–0047] Agency Information Collection Activities; Proposed eCollection, eComments Requested; Extension Without Change of a Previously Approved Collection; Application for Import Quota for Ephedrine, Pseudoephedrine, and Phenylpropanolamine; DEA Form 488 Drug Enforcement Administration, Department of Justice. ACTION: 30-Day notice. AGENCY: The Department of Justice, Drug Enforcement Administration (DEA), is submitting the following information collection request to the Office of Management and Budget for review and approval in accordance with the Paperwork Reduction Act of 1995. The proposed information collection was previously published in the Federal Register, on December 14, 2018, allowing for a 60 day comment period. DATES: Comments are encouraged and will be accepted for 30 days until March 29, 2019. FOR FURTHER INFORMATION CONTACT: If you have additional comments, especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Kathy L. Federico, Diversion Control Division, Drug Enforcement Administration; Mailing Address: 8701 SUMMARY: E:\FR\FM\27FEN1.SGM 27FEN1 6440 Federal Register / Vol. 84, No. 39 / Wednesday, February 27, 2019 / Notices Morrissette Drive, Springfield, Virginia 22152; Telephone: (202) 598–6812. Written comments and/or suggestions may also be sent to the Office of Management and Budget, Office of Information and Regulatory Affairs, Attention Department of Justice Desk Officer, Washington, DC 20503, or sent to OIRA_submission@omb.eop.gov. SUPPLEMENTARY INFORMATION: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the proposed collection of information, including the validity of the methodology and assumptions used; —Evaluate whether and if so how the quality, utility, and clarity of the information proposed to be collected can be enhanced; and —Minimize the burden of the collection of information on those who are to respond, including through the use of appropriate automated, electronic, mechanical, or other technological collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. amozie on DSK3GDR082PROD with NOTICES1 Overview of This Information Collection 1. Type of Information Collection: Extension of a currently approved collection. 2. Title of the Form/Collection: Application for Import Quota for Ephedrine, Pseudoephedrine, and Phenylpropanolamine. 3. The agency form number, if any, and the applicable component of the Department sponsoring the collection: DEA Form 488. The applicable component within the Department of Justice is the Drug Enforcement Administration, Diversion Control Division. 4. Affected public who will be asked or required to respond, as well as a brief abstract: Affected public (Primary): Business or other for-profit. Affected public (Other): Not-for-profit institutions; Federal, State, local, and tribal governments. Abstract: Pursuant to 21 U.S.C. 952 and 21 CFR 1315.34, any person who VerDate Sep<11>2014 17:07 Feb 26, 2019 Jkt 247001 desires to import the List I chemicals Ephedrine, Pseudoephedrine, or Phenylpropanolamine during the next calendar year must apply on DEA Form 488 for an import quota for each such List I chemical. 5. An estimate of the total number of respondents and the amount of time estimated for an average respondent to respond: The DEA estimates 49 respondents complete 126 DEA Form 488 applications annually, and that each form takes 0.5 hours to complete. Respondents complete a separate DEA Form 488 for each List I chemical for which quota is sought. 6. An estimate of the total public burden (in hours) associated with the proposed collection: The DEA estimates this collection takes a total of 63 annual burden hours. If additional information is required, please contact: Melody Braswell, Department Clearance Officer, United States Department of Justice, Justice Management Division, Policy and Planning Staff, Two Constitution Square, 145 N Street NE, Suite 3E.405B, Washington, DC 20530. Dated: February 22, 2019. Melody Braswell, Department Clearance Officer for PRA, U.S. Department of Justice. [FR Doc. 2019–03354 Filed 2–26–19; 8:45 am] BILLING CODE 4410–09–P DEPARTMENT OF JUSTICE [OMB Number 1121–0339] Agency Information Collection Activities; Proposed eCollection eComments Requested; Extension of a Currently Approved Collection; Comments Requested: Generic Clearance for Cognitive, Pilot and Field Studies for Bureau of Justice Statistics Data Collection Activities Bureau of Justice Statistics, Department of Justice. ACTION: 30-Day notice. AGENCY: The Department of Justice (DOJ), Office of Justice Programs (OJP), Bureau of Justice Statistics (BJS), intends to request approval from the Office of Management and Budget (OMB) for a generic information collection clearance that will allow BJS to conduct a variety of cognitive, pilot, and field test studies. BJS will submit the request for review and approval in accordance with the Paperwork Reduction Act of 1995. Over the next three years, BJS anticipates undertaking a variety of new surveys and data collections, as well as SUMMARY: PO 00000 Frm 00087 Fmt 4703 Sfmt 4703 reassessing ongoing statistical projects, across a number of areas of criminal justice, including law enforcement, courts, corrections, and victimization. This work will entail developing new survey instruments, redesigning and/or modifying existing surveys, procuring administrative data from state and local government entities, and creating or modifying establishment surveys. BJS will engage in cognitive, pilot, and field test activities to refine instrumentation and data collection methodologies, inform BJS data collection protocols, develop accurate estimates of respondent burden, and minimize respondent burden associated with each new or modified data collection. BJS envisions using a variety of techniques, including (but not limited to): Tests of different types of survey and data collection operations; focus groups; cognitive testing; pilot testing; exploratory interviews; experiments with questionnaire design; and usability testing of electronic data collection instruments. Following standard Office of Management and Budget (OMB) requirements, BJS will submit a change request to OMB individually for every group of data collection activities undertaken under this generic clearance. BJS will provide OMB with a copy of the individual instruments or questionnaires (if one is used), as well as other materials describing the project. DATES: Comments are encouraged and will be accepted for 30 days until March 29, 2019. FOR FURTHER INFORMATION CONTACT: If you have additional comments especially on the estimated public burden or associated response time, suggestions, or need a copy of the proposed information collection instrument with instructions or additional information, please contact Devon Adams, Bureau of Justice Statistics, 810 Seventh Street NW, Washington, DC 20531 (email: Devon.Adams@usdoj.gov; telephone: 202–307–0765). SUPPLEMENTARY INFORMATION: Written comments and suggestions from the public and affected agencies concerning the proposed collection of information are encouraged. Your comments should address one or more of the following four points: —Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the Bureau of Justice Statistics, including whether the information will have practical utility; —Evaluate the accuracy of the agency’s estimate of the burden of the E:\FR\FM\27FEN1.SGM 27FEN1

Agencies

Department of Justice

[Federal Register Volume 84, Number 39 (Wednesday, February 27, 2019)]
[Notices]
[Pages 6439-6440]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-03354]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

[OMB Number 1117-0047]


Agency Information Collection Activities; Proposed eCollection, 
eComments Requested; Extension Without Change of a Previously Approved 
Collection; Application for Import Quota for Ephedrine, 
Pseudoephedrine, and Phenylpropanolamine; DEA Form 488

AGENCY: Drug Enforcement Administration, Department of Justice.

ACTION: 30-Day notice.

-----------------------------------------------------------------------

SUMMARY: The Department of Justice, Drug Enforcement Administration 
(DEA), is submitting the following information collection request to 
the Office of Management and Budget for review and approval in 
accordance with the Paperwork Reduction Act of 1995. The proposed 
information collection was previously published in the Federal 
Register, on December 14, 2018, allowing for a 60 day comment period.

DATES: Comments are encouraged and will be accepted for 30 days until 
March 29, 2019.

FOR FURTHER INFORMATION CONTACT: If you have additional comments, 
especially on the estimated public burden or associated response time, 
suggestions, or need a copy of the proposed information collection 
instrument with instructions or additional information, please contact 
Kathy L. Federico, Diversion Control Division, Drug Enforcement 
Administration; Mailing Address: 8701

[[Page 6440]]

Morrissette Drive, Springfield, Virginia 22152; Telephone: (202) 598-
6812. Written comments and/or suggestions may also be sent to the 
Office of Management and Budget, Office of Information and Regulatory 
Affairs, Attention Department of Justice Desk Officer, Washington, DC 
20503, or sent to OIRA_submission@omb.eop.gov.

SUPPLEMENTARY INFORMATION: Written comments and suggestions from the 
public and affected agencies concerning the proposed collection of 
information are encouraged. Your comments should address one or more of 
the following four points:

--Evaluate whether the proposed collection of information is necessary 
for the proper performance of the functions of the agency, including 
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the 
proposed collection of information, including the validity of the 
methodology and assumptions used;
--Evaluate whether and if so how the quality, utility, and clarity of 
the information proposed to be collected can be enhanced; and
--Minimize the burden of the collection of information on those who are 
to respond, including through the use of appropriate automated, 
electronic, mechanical, or other technological collection techniques or 
other forms of information technology, e.g., permitting electronic 
submission of responses.

Overview of This Information Collection

    1. Type of Information Collection: Extension of a currently 
approved collection.
    2. Title of the Form/Collection: Application for Import Quota for 
Ephedrine, Pseudoephedrine, and Phenylpropanolamine.
    3. The agency form number, if any, and the applicable component of 
the Department sponsoring the collection: DEA Form 488. The applicable 
component within the Department of Justice is the Drug Enforcement 
Administration, Diversion Control Division.
    4. Affected public who will be asked or required to respond, as 
well as a brief abstract:
    Affected public (Primary): Business or other for-profit.
    Affected public (Other): Not-for-profit institutions; Federal, 
State, local, and tribal governments.
    Abstract: Pursuant to 21 U.S.C. 952 and 21 CFR 1315.34, any person 
who desires to import the List I chemicals Ephedrine, Pseudoephedrine, 
or Phenylpropanolamine during the next calendar year must apply on DEA 
Form 488 for an import quota for each such List I chemical.
    5. An estimate of the total number of respondents and the amount of 
time estimated for an average respondent to respond: The DEA estimates 
49 respondents complete 126 DEA Form 488 applications annually, and 
that each form takes 0.5 hours to complete. Respondents complete a 
separate DEA Form 488 for each List I chemical for which quota is 
sought.
    6. An estimate of the total public burden (in hours) associated 
with the proposed collection: The DEA estimates this collection takes a 
total of 63 annual burden hours.
    If additional information is required, please contact: Melody 
Braswell, Department Clearance Officer, United States Department of 
Justice, Justice Management Division, Policy and Planning Staff, Two 
Constitution Square, 145 N Street NE, Suite 3E.405B, Washington, DC 
20530.

    Dated: February 22, 2019.
Melody Braswell,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2019-03354 Filed 2-26-19; 8:45 am]
 BILLING CODE 4410-09-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.